Published in
Elsevier, The Lancet, 10064(389), p. 67-76, 2017
DOI: 10.1016/s0140-6736(16)32455-2
Links
Tools
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Journal article published in 2017 by
Arjun V. Balar 
,
Matthew D. Galsky,
Jonathan E. Rosenberg,
Thomas Powles,
Daniel P. Petrylak,
Joaquim Bellmunt,
Yohann Loriot,
Andrea Necchi,
Jean Hoffman-Censits,
Jose Luis Perez-Gracia,
Nancy A. Dawson,
Michiel S. van der Heijden,
Robert Dreicer,
Sandy Srinivas,
Margitta M. Retz
and other authors.
,
Matthew D. Galsky,
Jonathan E. Rosenberg,
Thomas Powles,
Daniel P. Petrylak,
Joaquim Bellmunt,
Yohann Loriot,
Andrea Necchi,
Jean Hoffman-Censits,
Jose Luis Perez-Gracia,
Nancy A. Dawson,
Michiel S. van der Heijden,
Robert Dreicer,
Sandy Srinivas,
Margitta M. Retz
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 